Kraig Biocraft Develops Immortalized Silk Gland Cell Line for Expanded Biotech Applications
Kraig Biocraft Laboratories (OTC: KBLB) announced a breakthrough in developing an immortalized silkworm silk gland cell line, which could enable the company to expand beyond spider silk textiles into recombinant protein manufacturing and biotechnology applications. Early testing showed strong viability and expression capabilities for scalable production.
Topics: immortalized_cell_line industrial_biotechnology recombinant_protein_production